www.fdanews.com/articles/81482-johnson-johnson-initiated-with-buy
JOHNSON & JOHNSON INITIATED WITH 'BUY'
October 7, 2005
Analysts at UBS initiate coverage of Johnson & Johnson with a "buy"
rating. The target price is set to $80.
Newratings